| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 7 | |
| #2 | WIPO (World Intellectual Property Organization) | 2 | |
| #3 | Canada | 1 | |
| #4 | EAPO (Eurasian Patent Organization) | 1 | |
| #5 | France | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Vermot-Desroches Claudine | 9 |
| #2 | Diaz Jean-Jacques | 3 |
| #3 | Saurin Jean-Christophe | 3 |
| #4 | Albaret Marie Alexandra | 3 |
| #5 | Mertani Hichem Claude | 3 |
| #6 | Doerflinger Franck | 3 |
| #7 | Vuillermoz Boris Sebastien | 3 |
| #8 | Vuillermoz Boris | 3 |
| #9 | Lavocat Emilie | 3 |
| #10 | Vermot-Descroches Claudine Brigitte Fernande | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2019011918A1 | Treatment of b cell malignancies using afucosylated pro-apoptotic anti-cd19 antibodies in combination with anti cd20 antibodies or chemotherapeutics | |
| EP3444272A1 | Treatment of ck8 positive cancers in relation with k-ras gene status | |
| EP3189078A1 | Anti-ck8 antibodies for use in the treatment of cancers | |
| EP2596024A1 | Anti-cd19 antibody having adcc function with improved glycosylation profile | |
| EP3461843A2 | Anti-cd19 antibody having adcc and cdc functions and improved glycosylation profile |